Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 23 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fortress Biotech, Inc. | 4,586,841 | reported | 18 Mar 2026 | tx 73+18,183,677−27,175 |
| CYPRESS BIOSCIENCE INC | 2,576,548 | reported | 09 Jan 2004 | tx 4−200,000 |
| NOVADEL PHARMA INC | 2,137,660 | reported | 22 Jan 2007 | tx 16+4,632,347−8,251,334 |
| JAVELIN PHARMACEUTICALS, INC | 1,639,173 | reported | 28 Dec 2006 | tx 2−625,000 |
| Paramount Acquisition Corp | 1,304,574 | reported | 23 Feb 2007 | tx 38+1,316,003 |
| Innovive Pharmaceuticals, Inc. | 265,215 | reported | 24 Apr 2007 | tx 1+120,868 |
| Alaunos Therapeutics, Inc. | 250,188 | reported | 03 May 2006 | tx 1+250,188 |
| Journey Medical Corp | 211,146 | reported | 05 Aug 2025 | tx 7+211,146 |
| GENTA INC DE/ | 184,866 | reported | 05 May 2004 | tx 36+3,992,730−18,270,709 |
| MUSTANG BIO, INC. | 60,525 | reported | 05 Jul 2023 | tx 16+413,038 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Mar 2026 | GRANT_AWARD | Fortress Biotech, Inc. | 475,424 | 0.00 USD | |
| 05 Aug 2025 | GRANT_AWARD | Journey Medical Corp | 50,000 | 0.00 USD | |
| 25 Jun 2025 | GRANT_AWARD | Journey Medical Corp | 7,173 | 0.00 USD | |
| 29 May 2025 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 50,000 | 1.29 USD | |
| 28 May 2025 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 12,195 | 0.00 USD | |
| 30 May 2025 | TENDER | Checkpoint Therapeutics, Inc. | 207,007 | — | |
| 01 Jan 2025 | GRANT_AWARD | Fortress Biotech, Inc. | 454,153 | 0.00 USD | |
| 13 Dec 2024 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 12,638 | 0.00 USD | |
| 23 Sept 2024 | PURCHASE | Fortress Biotech, Inc. | 763,359 | 1.84 USD | anomaly |
| 23 Sept 2024 | PURCHASE | Fortress Biotech, Inc. | 763,359 | 0.13 USD | deriv |
| 23 Sept 2024 | GRANT_AWARD | AVENUE THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 11 Jul 2024 | PURCHASE | Fortress Biotech, Inc. | 5,000 | 7.48 USD | |
| 09 Jul 2024 | PURCHASE | Fortress Biotech, Inc. | 5,000 | 7.39 USD | |
| 08 Jul 2024 | PURCHASE | Fortress Biotech, Inc. | 5,000 | 7.35 USD | |
| 08 Jul 2024 | GRANT_AWARD | Journey Medical Corp | 9,728 | 0.00 USD | |
| 28 Jun 2024 | PURCHASE | Fortress Biotech, Inc. | 20,000 | 1.64 USD | |
| 16 May 2024 | PURCHASE | Fortress Biotech, Inc. | 10,000 | 1.76 USD | |
| 14 May 2024 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 32,051 | 0.00 USD | |
| 14 May 2024 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 50,000 | 0.00 USD | |
| 25 Mar 2024 | PURCHASE | Journey Medical Corp | 10,000 | 3.04 USD | |
| 22 Mar 2024 | PURCHASE | Journey Medical Corp | 20,000 | 3.40 USD | |
| 05 Jan 2024 | PURCHASE | Fortress Biotech, Inc. | 50,000 | 2.38 USD | |
| 01 Jan 2024 | GRANT_AWARD | Fortress Biotech, Inc. | 216,465 | 0.00 USD | |
| 14 Nov 2023 | PURCHASE | Fortress Biotech, Inc. | 1,567,515 | 1.70 USD | anomaly |
| 14 Nov 2023 | PURCHASE | Fortress Biotech, Inc. | 1,567,515 | 0.00 USD | deriv |
5 purchases reported after at least 12 months of silence — most recent on 18 Mar 2022.